We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNA Modifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).
The journal Genomics,Proteomics&Bioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Autumn of 2024)on the topic of"Biomedical Big Data in Blood".
We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNAModifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).More than 100 distinct chem...We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNAModifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).More than 100 distinct chemical modifications to RNA have been characterized so far.展开更多
We are pleased to announce a special issue,to be published in the Winter of 2022,on"Artificial Intelligence in Omics"in the journal Genomics,Proteomics&Bioinformatics(GPB).In recent years,artificial inte...We are pleased to announce a special issue,to be published in the Winter of 2022,on"Artificial Intelligence in Omics"in the journal Genomics,Proteomics&Bioinformatics(GPB).In recent years,artificial intelligence(AI)has enabled breakthroughs across diverse biomedical fields,such as protein structure prediction,disease diagnosis,and drug discovery.展开更多
The journal Genomics,Proteomics&Bioinformatics (GPB) is now inviting submissions for a special issue(to be published in the Summer of 2023) on the topic of"Biomedical Big Data in Blood".It took 15 years,...The journal Genomics,Proteomics&Bioinformatics (GPB) is now inviting submissions for a special issue(to be published in the Summer of 2023) on the topic of"Biomedical Big Data in Blood".It took 15 years,3 billion USD,and thousands of top scientists from all over the world to complete the Human Genome Project (HGP).With the advances of genome-wide sequencing technologies and bioinformatics approaches,a large number of datasets of normal and malignant hematopoiesis have been generated and made public to researchers around the world.Collection and integration of these datasets greatly facilitate basic research and clinical diagnosis and treatment of blood disorders.展开更多
We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNA Modifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).More than 100 distinct che...We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNA Modifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).More than 100 distinct chemical modifications to RNA have been characterized so far.展开更多
The journal Genomics,Proteomics&Bioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Summer of 2023)on the topic of“Biomedical Big Data in Blood”.It took 15 years,3 billion U...The journal Genomics,Proteomics&Bioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Summer of 2023)on the topic of“Biomedical Big Data in Blood”.It took 15 years,3 billion USD,and thousands of top scientists from all over the world to complete the Human Genome Project(HGP).With the advances of genome-wide sequencing technologies and bioinformatics approaches,a large number of datasets of normal and malignant hematopoiesis have been generated and made public to researchers around the world.Collection and integration of these datasets greatly facilitate basic research and clinical diagnosis and treatment of blood disorders.展开更多
文摘We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNA Modifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).
文摘The journal Genomics,Proteomics&Bioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Autumn of 2024)on the topic of"Biomedical Big Data in Blood".
文摘We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNAModifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).More than 100 distinct chemical modifications to RNA have been characterized so far.
文摘We are pleased to announce a special issue,to be published in the Winter of 2022,on"Artificial Intelligence in Omics"in the journal Genomics,Proteomics&Bioinformatics(GPB).In recent years,artificial intelligence(AI)has enabled breakthroughs across diverse biomedical fields,such as protein structure prediction,disease diagnosis,and drug discovery.
文摘The journal Genomics,Proteomics&Bioinformatics (GPB) is now inviting submissions for a special issue(to be published in the Summer of 2023) on the topic of"Biomedical Big Data in Blood".It took 15 years,3 billion USD,and thousands of top scientists from all over the world to complete the Human Genome Project (HGP).With the advances of genome-wide sequencing technologies and bioinformatics approaches,a large number of datasets of normal and malignant hematopoiesis have been generated and made public to researchers around the world.Collection and integration of these datasets greatly facilitate basic research and clinical diagnosis and treatment of blood disorders.
文摘We are very pleased to announce a special issue,to be published in the Summer of 2023,on“RNA Modifications and Epitranscriptomics”in the journal Genomics,Proteomics&Bioinformatics(GPB).More than 100 distinct chemical modifications to RNA have been characterized so far.
文摘The journal Genomics,Proteomics&Bioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Summer of 2023)on the topic of“Biomedical Big Data in Blood”.It took 15 years,3 billion USD,and thousands of top scientists from all over the world to complete the Human Genome Project(HGP).With the advances of genome-wide sequencing technologies and bioinformatics approaches,a large number of datasets of normal and malignant hematopoiesis have been generated and made public to researchers around the world.Collection and integration of these datasets greatly facilitate basic research and clinical diagnosis and treatment of blood disorders.
